,,,,,,hummm,,,,,BDA is correct from what I saw in the slides when he says the slides have basically the same info as what has been released this morning. It certainly makes for a two headed arrow to commercialization,,,our eggs are not all in one basket for sure!

A quick question as to carrying into the next CKD trial. Do we have to perform a Phase ll trial and then follow up into a Phase lll or is it possible to combine the trials? Something seems to tell me from the past that we might be able to skip a grade so to speak!

There should be ample data on the safety of 208 by then one would think.

Also, if a share price of say $4.00 comes to fruition before August one might surmise DM could have a stacked hand in negotiating with KD and HL. I am crossing my fingers.

This news release makes for optimistic support for a much higher share price over the next 2 quarters. jmo

Comments appreciated.